Recorded fact · drug.label_indication
drug.label_indication for ribociclib|metastatic-breast-cancer
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact dd88bd48 resolves to.
The record
| Fact id | dd88bd48ed44f8a2675a3796 |
|---|---|
| Entity | drug: ribociclib|metastatic-breast-cancer |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260701 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
for the treatment of adults with HR-positive, HER2-negative advanced or metastatic breast cancer in combination with: an aromatase inhibitor as initial endocrine-based therapy;
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 36f1ce41f4f2483a2fd7b26ce6d19c676cd58a3ab8482e91fccab4bf171f9b13.
The value
{
"ingredient": "RIBOCICLIB",
"conditionId": "metastatic-breast-cancer",
"conditionName": "Metastatic Breast Cancer",
"matchedAlias": "metastatic breast cancer",
"context": "indication",
"brand": "KISQALI",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "aaeaef94-f3f5-4367-8ea2-b181d7be2da8",
"labelEffectiveTime": "20260701",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 8238c5ec849ee868195719873490cce8fc5d0574c7aeb9ff762ce73f35e0773d.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.